<DOC>
	<DOCNO>NCT03076138</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy gene-activated bone substitute consist octacalcium phosphate plasmid DNA encode vascular endothelial growth factor ( VEGF ) maxillofacial bone regeneration . The patient congenital acquire maxillofacial bone defect alveolar ridge atrophy enrol .</brief_summary>
	<brief_title>Gene-activated Bone Substitute Maxillofacial Bone Regeneration</brief_title>
	<detailed_description>All participant study receive standard treatment accord medical care standard diseases pathological condition characterize maxillofacial bone defect and/or alveolar ridge atrophy . Bone graft procedure part surgical treatment perform use investigated medical device . The safety efficacy implant gene-activated bone substitute evaluate clinical examination , comprehensive laboratory test , computer tomography within 6 month surgery .</detailed_description>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Tooth Loss</mesh_term>
	<mesh_term>Bone Cysts</mesh_term>
	<criteria>obtain voluntary informed consent participation clinical study ; congenital acquire maxillofacial bone defect ( socket extract teeth , bone defect injury , surgery , removal benign neoplasms pseudotumors , etc . ) alveolar ridge atrophy . able unwilling give voluntary inform consent study follow requirement clinical study ; decompensated chronic visceral disease ; clinically significant laboratory abnormality ; HIV , HBV HCV antibodies serum ; alcohol consumption within 4 day prior study ; history drug addiction ; participation clinical trial ( administration study product ) within 3 month prior study ; condition limit study compliance ( dementia , psychoneurological disease , drug addiction , alcoholism , etc . ) ; pregnancy lactation ; malignancy include posttreatment period ( surgical , chemotherapy , radiation therapy alone different combination ) less 5 year prior study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Gene-activated matrix</keyword>
	<keyword>Bone substitute</keyword>
	<keyword>Bone grafting</keyword>
	<keyword>Dental implantation</keyword>
	<keyword>gene therapy</keyword>
	<keyword>plasmid DNA</keyword>
	<keyword>VEGF gene</keyword>
	<keyword>octacalcium phosphate</keyword>
</DOC>